Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory
Abstract:
The disclosure relates generally to neurodegenerative disorders and more specifically to a group of presenilin/G-protein/c-src binding polypeptides and methods of use for modulating signaling and progression of Alzheimer's disease.
Information query
Patent Agency Ranking
0/0